HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration.

AbstractPURPOSE:
To investigate the aqueous and vitreous penetration of levofloxacin, the drug was administered topically and/or orally to patients undergoing vitrectomy.
METHODS:
Thirty-six patients undergoing initial vitrectomy with phacoemulsification and aspiration (PEA) were enrolled, and were divided randomly into three groups. Group 1 was treated with topical application of levofloxacin (three times on the day before surgery and seven times on the day of surgery), Group 2 received oral administration of levofloxacin (200 mg twice on the day before surgery and 200 mg at 3 hours before surgery), and Group 3 received both topical and oral levofloxacin according to the above schedules. The concentration of levofloxacin was measured in aqueous humor and vitreous fluid samples obtained during surgery.
RESULTS:
In Groups 1, 2, and 3, the mean levofloxacin concentration in aqueous humor was 0.765+/-0.624 micro g/mL, 1.279+/-0.440 micro g/mL, and 1.823+/-0.490 micro g/mL, respectively, while the mean levofloxacin concentration in vitreous fluid was <0.02 micro g/mL, 1.455+/-0.445 micro g/mL, and 1.369+/-0.530 micro g/mL, respectively.
CONCLUSIONS:
Oral administration of levofloxacin at a dose of 400 mg/day was sufficient for the prophylaxis of ocular infections, because the drug concentrations in both aqueous humor and vitreous fluid were higher than the MIC90 values for major ocular pathogens. Topical application of levofloxacin achieved adequate drug levels in aqueous humor, but not in vitreous fluid, while combined topical and oral administration had an additive effect on the drug concentration in aqueous humor.
AuthorsH Sakamoto, M Sakamoto, Y Hata, T Kubota, T Ishibashi
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) 2007 May-Jun Vol. 17 Issue 3 Pg. 372-6 ISSN: 1120-6721 [Print] United States
PMID17534819 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
  • Levofloxacin
  • Ofloxacin
Topics
  • Administration, Oral
  • Administration, Topical
  • Aged
  • Anti-Bacterial Agents (pharmacokinetics, pharmacology)
  • Aqueous Humor (metabolism)
  • Bacteria (drug effects)
  • Biological Availability
  • Chromatography, High Pressure Liquid
  • Female
  • Humans
  • Levofloxacin
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Ofloxacin (pharmacokinetics, pharmacology)
  • Phacoemulsification
  • Vitrectomy
  • Vitreous Body (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: